Desafios para a coleta de sangue e análise bioquímica em um grande estudo multicêntrico realizado em escolas com adolescentes: lições do ERICA no Brasil Desafíos para la recolección de sangre y el análisis bioquímico en un gran estudio multicéntrico con adolescentes en las escuelas: lecciones del ERICA en Brasil 
Introduction
Cardiovascular diseases (CVD) are responsible for 30% of deaths worldwide. The prevention and control of the major risk factors for CVD would theoretically reduce world mortality related to these diseases by half 1 . In Brazil, CVD is the main cause of death and the major contributor to hospitalization costs 2 . Complex interactions between behavioral and biological (physiological, biochemical, and inflammatory) risk factors during childhood and especially in adolescence are important in the pathogenesis of atherosclerotic disease, the main CVD in adults 3 .
Collection of biological material and biomarkers are important when assessing metabolic disorders in epidemiological studies. A standardized collection of biologic samples poses challenges that include complex storage and transport logistics of biological material in multicenter epidemiological studies. Processes and handling in the pre-analytical phase, for example, may be responsible for 32% to 75% of the total variation of results in a laboratory test 4 . In developing countries, conducting this type of study is even more challenging, due to difficulties in importing equipment and laboratory supplies, airway infrastructure issues, and inadequate number of transport routes, all of which make consistent information on biomarkers associated with CVD scarce in these populations.
In Brazil, in addition to the already mentioned difficulties, the continental extension of the country, regional differences, and logistical issues may add even more barriers to biomarker studies. Therefore, the Study of Cardiovascular Risk in Adolescents (ERICA; Estudo de Riscos de Cardiovasculares em Adolescentes in Portuguese) was set up to overcome these barriers. Its objectives were to estimate the prevalence of diabetes, hypertension, and metabolic syndrome, as well as other cardiovascular risk factors in adolescents aged from 12 to 17 years, living in Brazilian cities with more than 100,000 inhabitants. Therefore, the objective of this study was to describe the methodological aspects related to planning and logistics of blood collection, as well as to report the pertaining results of the collection, transport, and storage of blood samples, and exams in ERICA.
Methods

ERICA's sample design and data collection
ERICA is a national school-based cross-sectional study. A total of 1,247 (925 with blood collect) schools in 124 municipalities (45.4% of the possible municipalities) were selected. Data collection was performed between February 2013 and November 2014. The target population was divided into 32 geographic strata: 27 state capitals and five more strata representing other municipalities with more than 100,000 inhabitants in each one of the macro regions of the country.
Schools were selected according to proportional probability for size, which was defined by the ratio of the number of eligible students in the school and the distance between the school and the state capital. Issues such as school location (urban or rural area) and administration (public or private) were also considered. This strategy allowed to center the sample in the vicinity of the capital, which reduced costs and facilitated the logistics of the study, especially concerning blood collection and adequacy of pre-analytical procedures.
In the second sample stage, three classes in each school were selected, considering combinations of the class period (morning or afternoon) and eligible grades (7th, 8th, 9th grades from elementary school and 1st, 2nd, and 3rd grades from high school). All students of randomly selected classes were invited to participate in ERICA, but only students of the morning classes participated in fasting blood collection and only adolescents aged between 12 and 17 years were eligible. Details of ERICA's study design and sampling are available in other studies 5, 6 .
In summary, the first selected schools were contacted and invited to participate in the study. The students attending the randomly selected classes received information regarding the study. If they agreed to participate, they were registered on the ERICA online system and had their visits scheduled. The data collection in each class was held over two nonconsecutive days; on the first day, a questionnaire was applied using an electronic data collector (Personal Digital Assistant -PDA), anthropometric (weight, height, waist and arm circumference) and blood pressure measurements were taken, and
Cad. Saúde Pública 2017; 33(4):e00122816 a 24-hour dietary recall was conducted. On the second day, a fasting blood sample was collected; as described below. Finally, two weeks after data collection, a member of the research team returned to the schools to deliver the results and conduct a second 24-hour dietary recall in a sub-sample of students. All adolescents who agreed to participate in the study and their parents or legal guardians signed the informed consent forms. ERICA was approved by the local Ethics Research Committee in each of the 27 Federation Units.
Blood collection and logistics: pre-analytical, quality indicators, and analytical care ERICA's research protocol was standardized across all 27 centers. For this purpose, it used a single laboratory, in which all biochemical analyses of the study were conducted. The reference laboratory, located in the city of Cascavel (Paraná State), included a network of 60 partner laboratories distributed by ERICA's centers.
In addition to providing the infrastructure that contributed to the completion of the study, the reference laboratory was certified by the National Program of Quality Control (PNCQ; https:// www.pncq. The reference laboratory identified one or more local partner laboratories in each of the 27 centers to perform the collections of blood samples at schools. All laboratories followed exactly the same protocol throughout the study, from scheduling the blood collection to transportation to the central unit. Each laboratory was informed, via the reference laboratory, about the date, time, and location of the school in which to conduct the blood collection. The charges involving blood collection, transportation, and exams were agreed with the central laboratory as required at baseline by ERICA's coordination.
Around ten days before the blood collection at schools, the central laboratory received a spreadsheet generated by ERICA's web system containing the name and numeric code of students in each enrolled class. This information was used to produce the tube labels with bar codes to allow the linkage of the results of exams with participants' information in the ERICA dataset. Every local laboratory obtained an identical kit for blood collection for each participant from the reference laboratory. The kit was composed of the following materials: four labels with bar code for identification of tubes; a zip bag for sending the samples separately for each participant; a tube with gel for measurements of total cholesterol, HDL cholesterol, triglycerides, and insulin; a fluoridated tube for measurement of glucose and a transport tube for the transfer of aliquot of plasma fluoride; a tube with ethylenediaminetetraacetic acid (EDTA) for measuring glycated hemoglobin (HbA1c); a Pasteur's pipette for aliquot of plasma fluoride; a needle for vacuum collection; and a swab of alcohol for antisepsis of the site of collection and occlusive dressing. Figure 1 shows the logistics of the data collection in ERICA and the details of the blood collection for biochemical analyses. Blood samples were drawn after at least 12 hours of fasting. To confirm the compliance, a pre-examination questionnaire including questions about time of last food intake, bedtime and wake-up time on the day before the data collection, if any food or liquid was ingested, the use of medication on the day before blood collection (water and medications were allowed) was completed by each participant. For those who did not comply with the 12-hour fasting, a new attempt to collect the blood sample was scheduled appropriately. Additionally, in some specific cases, a direct collection at the local laboratory was offered.
All students were informed about the procedures before the blood samples were drawn and were free to withdraw at any point. First, correct identification was verified with the adolescent. Collection was performed using a vacuum needle for multiple collections, after asepsis of the collection site with alcohol, and a garroting time of less than one minute. After finishing the blood collection, all students received a snack. Industrialized foods were chosen mainly due to the durability of the products, which could be stored for approximately 90 days. The distribution to all Brazil regions was performed by a single company. All students provided four tubes, except in the four centers (Rio de Janeiro, Rio Grande do Sul, Federal District, and Ceará). In these centers, two additional gel tubes (4mL blood per tube) were collected and stored for future analyses.
After homogenization, the tubes were stored in thermal boxes (0-10°C) before transportation to the local partner and, subsequently, to the reference laboratory. All blood samples were prepared according to a standardized protocol at each local laboratory before transportation to the reference laboratory: gel tubes were centrifuged for 10 minutes at 3,000rpm and then cooled; the primary fluoride tube underwent the same procedure before the plasma was separated and transferred to the transport tube; EDTA tubes were directly refrigerated to maintain the temperature below 10°C. All samples with pre-analytical problems (e.g. hemolysis) were destroyed at the local laboratory. Samples were packed in bags and then in thermal boxes with dry ice and transported to the reference laboratory by air.
The temperature was checked at three control points: at arrival at the local laboratory site, before transport and finally at the reference laboratory. The samples were kept between 0°C and 10°C during the entire air routes; samples outside this temperature range were identified and evaluated for the occurrence of clotted, hemolytic, or lipemic samples. Results from samples outside the temperature range were compared with the others in crude analysis (mean and 95% confidence intervals). The acceptable analytic error by exam was established considering the biological and laboratory variations 7 .
Analyses, methods, and equipment used for dosage, mean coefficient of variation, and cut-off points for each exam are presented in Table 1 . Care taken by the reference laboratory in the review process included a semi-annual preventive maintenance of equipment to ensure proper performance. All batches were validated when changed, considering the historical value for each exam.
Quantitative internal quality control was evaluated by the coefficient of variation for each analyte according to standard procedures (Clinical Laboratory Improvement Amendments -CLIA; https:// www.cms.gov/clia) and rules of Westgard et al. 8 . Also, external controls by ControlLAB and PNCQ programs were periodically conducted for each of the analytes measured in ERICA. Exams with abnormal results were reassessed and results from the two tests compared and reported to the ERICA coordination team. Exams with discrepant values among the analyses were excluded.
Following analyses at the central reference laboratory, all results were sent to the ERICA central coordination center and entered into the ERICA database. All results were thereafter communicated in writing with the participants using a standardized data form. The need for any referrals to a local health service due to the presence of risk factors for CVD (e.g. dyslipidemia, hyperglycemia, or high HbA1c) was indicated in this form 5 . If urgent, for example in case of a suspected new diagnosis of diabetes, the ERICA central coordination immediately contacted the local coordinator, who was responsible for contacting the adolescents.
Biorepository
For adolescents living in the states of Rio de Janeiro, Rio Grande do Sul, Ceará, and Federal District, the serum was stored in local biorepositories to be used in future analyses. All centers with biorepositories had -80°C ultra-freezers for sample conservation, adequate laboratory structure, and trained professionals to perform preparation, separation, identification, and organization of the stored samples.
The two tubes with gel underwent the same standardization already described for other analyses. However, instead of being transported from schools to the local laboratory, they were sent directly to the four research centers. At arrival, samples were centrifuged (10 minutes at 3,000rpm) and the serum was aliquoted into cryotubes pre-identified by bar codes. Thereafter, the samples were fractionated according to the volume of blood, ranging from one to eight cryotubes containing 0.5mL of each serum. All samples collected at schools were delivered to the research center within two hours and procedures for storage did not exceed four hours. The samples were stored in cryoboxes and organized by school. The position of each sample (row and column in cryoboxes) was inserted into an electronic spreadsheet to facilitate future localization.
Results
In total, 284,247 exams were performed by the reference laboratory throughout the study, including 40,732 adolescents (12-17 years old). Less than 1% (n = 273) of the participants had some missing result. The main reasons for missing samples were insufficient amount of blood (61.2%), clotted, hemolytic, or lipemic samples (15%), and samples damaged during transport (14.6%). The percentage of blood collection coverage in each center took into consideration for the calculation the total number of eligible adolescents enrolled in ERICA and the final number of students who participated in the blood collection. Overall, 56.2% ERICA participants also had a blood sample collected, varying from 47.9% in Mato Grosso do Sul to 69.2% in Mato Grosso. In centers with biorepositories, the coverage varied from 48.2% in Rio de Janeiro to 60.6% in Rio Grande do Sul.
The logistics adopted in ERICA allowed 92.6% of the blood samples to reach the reference laboratory with the appropriate temperature range (0-10°C). In 17 of the 27 centers, there was no record of samples with temperatures over 10°C. The highest proportions samples with temperatures above 10°C were recorded in the North region, in the states of Amazonas (43.9%) and Pará (21.6%), and in the Northeast region, in Paraíba (19.2%) and Piauí (16.8%). Figure 2 shows box-plots for the temperature recorded in each of the centers. The median temperature ranged from 3.0°C in the Federal District to 8.0°C in Amazonas. The mean blood temperature in ERICA was 6.2°C (±3.3) and despite changes in temperature during transportation, no clinically relevant differences were observed when data from the five states with the greatest percentage of samples with abnormal temperature were analyzed (Table 2) . Figure 3 shows the geographic distribution of all cities where blood collection was performed. Considering only one transport between each city enrolled in blood collection and the reference laboratory, around 190,000km were covered. The distance of blood transportation varied from ≈ 350km from Londrina (state of Paraná) to ≈ 6,500km from Macapá (state of Amapá).
Regarding internal laboratory quality control, during the study period, the reference laboratory did not register coefficient of variation values for any of the analytes higher than the threshold value recommended by CLIA, which is below 5% for all analytes included in ERICA ( Table 1) . The external quality controls recorded satisfactory results in most instances (98.7%) and unsatisfactory results in only one (total cholesterol in August 2014).
Finally, four biorepositories were created with serum samples of 7,785 adolescents. In the centers of Rio de Janeiro, Rio Grande do Sul, Federal District, and Ceará: 7,301 (most of the cryotubes with 1mL), 12,719, 7,242, and 9,485 cryotubes with at least 0,5mL were stored, respectively. The main problem detected was hemolytic samples, which occurred in 11.4% of samples stored in Rio de Janeiro, the largest biorepository in ERICA. In this phase, all the collected samples were stored and information about problems as hemolysis will be considered before the future analysis.
Discussion
ERICA is a pioneer study that aims to evaluate lifestyle factors and cardiovascular biomarkers in adolescents from 27 centers in Brazil, a country of continental dimensions. In spite of the complexity of the logistics used for data collection of the blood specimens, the execution of the study proved to be adequate. The quality control procedures showed satisfactory performance, for all tests. Additionally, a biorepository was created at four different centers and these samples can be used in future studies involving inflammatory, nutritional, and other novel cardiovascular disease biomarkers.
Considering a decline in the participation rates in epidemiological studies in the last decades 9 , 72.9% of the adolescents completed ERICA's questionnaire (data not shown), and 56.2% of those eligible for blood samples agreed to participate in this part of the study. This participation rate is satisfactory, as compared to similar studies. In the Swedish part of the European Youth Heart Study, a school-based survey involving blood sampling obtained 49% (n = 1,137) of participation 10 . In the HELENA study, a school-based study conducted in 10 European cities with adolescents aged from 12 to 17 years, the overall participation rate was 67.1%. However, only one third of the adolescents were eligible for blood collection in that study and response rate was 68% (n = 1,076) 11 . Despite the relative lower response rate, in ERICA, 70.9% (n = 72,508) of the adolescents were eligible for blood collection, as they studied during the morning, and 40,732 students participated in the blood sampling.
The collection of biological material and the logistics of ERICA represented a decisive step for the proper assessment and interpretation of results. The centralization of the biochemical analyses in a reference laboratory with strict quality control procedures, assisted by local partner laboratories that managed the field collection, ensured standardization of measures. The centralization of biochemical analyses in a single laboratory has been adopted successfully by large-scale studies in Brazil 4 and abroad 12 . However, these studies involved a smaller number of participating centers compared to ERICA.
The strategy to centralize the laboratory tests aimed mainly to guarantee standardization of the methodology used, avoiding the inevitable variations between laboratories. With the care taken in ERICA, the laboratory results were more dependent on issues related to transportation and storage than collection procedures and samples analyses. The guidelines for standardization of actions adhered to by local laboratory partner, to minimize pre-analytical issues, also contributed to the qual- ity of the biochemical data achieved in ERICA. Furthermore, the initiative of using a pre-examination interview to confirm fasting was important, as it minimized the occurrence of inadequate fasting, which may be a problem in the pre-analytical phase.
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In large-scale studies, logistics to transport biological material is the aspect that deserves especially careful planning, since most of the samples need to be kept in a controlled temperature to preserve their integrity 13 . In ERICA, all steps were carefully monitored to ensure that the samples were maintained between 0°C and 10°C during the entire process. However, possibly because of the large geographical extent and differences in structure of transport in Brazil, some samples were delivered to the reference laboratory outside this temperature range, although they were all duly identified and evaluated regarding their biological integrity before being analyzed.
The highest incidences of temperatures above the appropriate range were recorded in the North and Northeast regions, areas associated with higher temperatures and longer distances to the reference laboratory. For example, in the five centers with higher rates of sample with altered temperature (> 10°C), blood collection was done with ambient temperature around 30°C (mean = 29°C; range 23-37°C). In the South region, most blood samples were collected during autumn and winter seasons (mean = 17°C; range 2-29°C). The majority of samples from this region were in the expected temperature. Furthermore, in the North and Northeast regions, airplane routes are limited and sometimes it was necessary to use other means of transportation for longer distances, which may have contributed to this result. However, a few hemolytic or lipemic samples were reported. In addition, preliminary comparative analyses did not show important variations in the test results due to temperature changes. It is also important to note that changes in temperature were rare. In the centers of the states of Goiás and Amazonas, temperature of samples changed during transport during 6 and 15 days, respectively, even though the data collection in these places extended more than 90 days.
Time is another important variable to be considered when evaluating sample stability before analysis. Kift et al. 14 examined the effect of storage conditions on sample stability and showed that triglycerides and HDL-c concentrations were increased after 16 hours in room temperature (≈ 20°C), but total cholesterol concentration remained stable. However, other authors reported that total cholesterol, triglycerides and HDL-c remain stable even after 24 hours up until 30°C, while glucose concentrations usually decreases progressively after six hours in room temperature 15, 16 . However, differences among studies, such as storage conditions, tube types, sample size and differences in the statistical techniques used to define significant change may affect results about stability. In ERICA, we compared the variation among samples in different categories of temperature with allowable total error for each analyte, and results suggest that observed differences were acceptable.
It is well known that there is a need to assess, monitor, and improve all pre-analytical and analytical steps of biomarker measurements in large studies 17 , including identification of participants and biological material collected, storage, and transportation of samples 13 . The ERICA study demonstrated that it is viable to carry out blood sampling, transportation, and analyses of cardio-vascular biomarkers on study participants across the entire country. The partnership with local centers allowed proper data collection, transportation, and storage of materials within the pre-established time and under appropriate conditions. The participation rate was satisfactory and the percentage of missing samples was low. It was also possible to store biological material, which will allow future analyses focused on novel biomarkers associated with CVD development. Description of the logistics used during blood collection and the difficulties experienced in the ERICA study can inform and facilitate the planning of future studies, especially in developing countries, where investigators will probably face challenges similar to those found in Brazil.
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